HL

Halma PLCLSE Halma Stock Report

Last reporting period 31 Mar, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

13.174

Large

Exchange

XLON - London Stock Exchange

HLMA.L Stock Analysis

HL

Neutral

Based on Eyestock quantitative analysis, HLMA.L`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

72/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

8.0 %

Undervalued

Market cap $B

13.174

Dividend yield

1.28 %

Shares outstanding

379.01 B

Halma Plc is a holding company which engages in the development, production and sale of hazard and life protection products. The company is headquartered in Amersham, Buckinghamshire and currently employs 7,779 full-time employees. The firm operates through three segments. The Safety segment provides technologies that save lives, protect infrastructure and enable safe movement, and also technologies that protect people and assets at work across a range of critical industrial and logistics operations. The segment provides solutions for elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, safe storage and transfer, and industrial access control. The Environmental & Analysis segment provides technologies, which monitor and protect the environment and ensure the quality and availability of life-critical resources. The segment’s solutions include environmental monitoring, gas detection, optical analysis, and water analysis and treatment. The Medical segment provides medical technologies, which enhance the quality of patients' lives and improve the quality of care delivered by healthcare providers.

View Section: Eyestock Rating